Polyarthritis, rash and lymphadenopathy: Case reports of two patients with angioimmunoblastic lymphadenopathy presenting to a rheumatology clinic

Clinical Rheumatology

Volumn 17, Issue 2, 1998, Pages 148-151

  Layton, M A ^a,c   Musgrove, C ^b   Dawes, P T ^a  

^a Staffordshire Rheumatology Centre   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c Staffordshire Rheumatology Centre   (United Kingdom)

Author keywords

Angioimmunoblastic lymphadenopathy; Arthritis; Rash

Indexed keywords

CHLOROQUINE; CODEINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; LEVAMISOLE; NAPROXEN; PARACETAMOL; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CASE REPORT; CELL INFILTRATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; RASH; SYNDROME;

AGED; ARTHRITIS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; EXANTHEMA; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPH NODES; MIDDLE AGED;

EID: 0031779171     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01452263     Document Type: Article

References (14)

1. Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1974;1:1070-3.
2. McHugh NJ, Campbell GJ, Landreth JJ, Laurent MR. Polyarthritis and angioimmunoblastic lymphadenopathy. Ann Rheum Dis 1987;46:555-8.
3. Boumpas DT, Wheby MS, Jaffe ES, et al. Synovitis in angioimmunoblastic lymphadenopathy with dysproteinaemia simulating rheumatoid arthritis. Arthritis Rheum 1990;33:578-82.
4. Siegert W, Nerl C, Agthe A, et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 1995;6:659-64.
5. Bistue R, Scognamillo C, Lovato G, et al. Seropositive polyarthritis as a presentation form of angioimmunoblastic lymphadenopathy. Medicina 1993;53:435-8.
6. Pruzanski W, Sutton DM, Pantolony D. Angioimmunoblastic lymphadenopathy: an immunochemical study. Clin lmmunol Immunopathol 1976;6:62-76.
7. Cullen MH, Stansfield AG, Oliver RTD, et al. Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med 1979;189:151-77.
8. Ozoran K, Turgay M, Kinikli G, et al. Angioimmunoblastic lymphadenopathy with disproteinaemia arising in a patient with rheumatoid arthritis. Scand J Rheumatol 1995;24:56-8.
9. Rosenstein ED, Wieczorac R, Raphael BG, Agus B. SLE and angioimmunoblastic lymphadenopathy: case report and review of the literature. Semin Arthritis Rheum 1986;16:146-51.
10. Stein H. Peripheral T-cell lymphomas. Ann Oncol 1991;2:163-70.
11. Siegert W, Agathe A, Griesser H, et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisolone with or without the COPBLAM/ IMVP-16 regimen. A multicentre study. Kiel Lymphoma Study Group. Ann Intern Med 1992;117:364-70.
12. Di Natale M, Biagioni P, Grassi M, et al. Angioimmunoblastic lymphadenopathy with dysproteinaemia: personal experience with 3 cases and review of the literature. Minerva Medica 1993;84:713-8.
13. Ohsaka A, Saito K, Sakai T, et al. Clinicopathologic and therapeutic aspects of angioimmunoblastic lymphadenopathy-related lesions. Cancer 1992;69:1259-67.
14. Murayama T, Imoto S, Takahashi T, et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinaemia with cyslosporin A. Cancer 1992;69:2567-70.